Related Experiment Video
Updated: May 24, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Analysis of precore/core covariances associated with viral kinetics and genotypes in hepatitis B e antigen-positive
Chun-Pei Cheng1, Pei-Fen Lee, Wen-Chun Liu
1Department of Computer Science and Information Engineering, National Cheng Kung University, Tainan, Taiwan.
Insights
Amino acid changes in Hepatitis B virus (HBV) correlate with viral activity and patient outcomes. Identifying these covariances aids in early treatment decisions for chronic hepatitis B patients.
Area of Science:
- Virology
- Immunology
- Genetics
Background:
- Hepatitis B virus (HBV) infection can lead to severe liver disease, including cirrhosis and hepatocellular carcinoma.
- Individual responses to HBV infection, including viral load kinetics and immune responses, are highly variable.
- Hepatitis B e antigen (HBeAg) and core antigen (HBcAg) are key indicators of active HBV replication.
Purpose of the Study:
- To identify amino acid covariances within the HBV precore/core open reading frame (ORF) in relation to viral kinetics, seroconversion, and genotypes.
- To understand the dynamic changes in these covariances over time during chronic HBV infection.
- To explore the potential of these covariances as biomarkers for predicting disease progression and guiding treatment.
Main Methods:
- A one-year follow-up study of 23 HBeAg-positive chronic hepatitis B patients.
- Monthly measurement of serum alanine aminotransferase, HBV DNA, and HBeAg levels for patient subgrouping.
- Direct sequencing and translation of HBV precore/core ORFs to analyze amino acid sequences and identify time-dependent covariances.
- Comparison of covariance patterns between different patient subgroups based on viral kinetics, HBeAg seroconversion status, and HBV genotype (B and C).
Main Results:
- Greater degrees of amino acid covariances were observed in fluctuating viral loads, non-seroconversion of HBeAg, and genotype C infections compared to stable, seroconverting, and genotype B infections.
- Identified mutation hotspots within covariances were linked to the HBV infection process, with a predominance in genotype C.
- Covariances were also detected in the early stage of infection, from baseline to peak HBV DNA levels, suggesting potential predictive value.
Conclusions:
- Amino acid covariances in the HBV precore/core region are significantly associated with viral kinetics, HBeAg seroconversion, and HBV genotype.
- Representative covariances identified in this study may serve as valuable markers for clinicians to tailor treatment strategies, even in asymptomatic patients during the early stages of HBV infection.
Abstract:
Hepatitis B virus (HBV) is one of the most common DNA viruses that can cause aggressive hepatitis, cirrhosis and hepatocellular carcinoma. Although many people are persistently infected with HBV, the kinetics in serum levels of viral loads and the host immune responses vary from person to person. HBV precore/core open reading frame (ORF) encoding proteins, hepatitis B e antigen (HBeAg) and core antigen (HBcAg), are two indicators of active viral replication. The aim of this study was to discover a variety of amino acid covariances in responses to viral kinetics, seroconversion and genotypes during the course of HBV infection. A one year follow-up study was conducted with a total number of 1,694 clones from 23 HBeAg-positive chronic hepatitis B patients. Serum alanine aminotransferase, HBV DNA and HBeAg levels were measured monthly as criteria for clustering patients into several different subgroups. Monthly derived multiple precore/core ORFs were directly sequenced and translated into amino acid sequences. For each subgroup, time-dependent covariances were identified from their time-varying sequences over the entire follow-up period. The fluctuating, wavering, HBeAg-nonseroconversion and genotype C subgroups showed greater degrees of covariances than the stationary, declining, HBeAg-seroconversion and genotype B. Referring to literature, mutation hotspots within our identified covariances were associated with the infection process. Remarkably, hotspots were predominant in genotype C. Moreover, covariances were also identified at early stage (spanning from baseline to a peak of serum HBV DNA) in order to determine the intersections with aforementioned time-dependent covariances. Preserved covariances, namely representative covariances, of each subgroup are visually presented using a tree-based structure. Our results suggested that identified covariances were strongly associated with viral kinetics, seroconversion and genotypes. Moreover, representative covariances may benefit clinicians to prescribe a suitable treatment for patients even if they have no obvious symptoms at the early stage of HBV infection.
Related Concept Videos
Viral Hepatitis I: Introduction
Hepatitis
Retroviruses
Cytomegalovirus Disease
Inhibitors of Viral Protein Synthesis
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

